{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:03:40Z","timestamp":1768003420724,"version":"3.49.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Sepsis-associated myocardial dysfunction is common in pediatric septic shock and negatively impacts outcomes. Early estimation of sepsis-associated myocardial dysfunction risk has the potential to inform clinical care and improve clinical trial design. The Pediatric Sepsis Biomarker Risk Model II is validated as a biomarker-based enrichment algorithm to discriminate children with septic shock with high baseline mortality probability. The objectives were to determine if Pediatric Sepsis Biomarker Risk Model biomarkers are associated with risk for sepsis-associated myocardial dysfunction in pediatric septic shock and to develop a biomarker-based model to reliably estimate sepsis-associated myocardial dysfunction risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Secondary analysis of prospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Single-center, quaternary-care PICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Children less than 18 years old admitted to the PICU from 2003 to 2018 who had Pediatric Sepsis Biomarker Risk Model biomarkers measured for determination of Pediatric Sepsis Biomarker Risk Model II mortality probability and an echocardiogram performed within 48 hours of septic shock identification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Pediatric Sepsis Biomarker Risk Model II mortality probability was calculated from serum biomarker concentrations and admission platelet count. Echocardiograms were reread by a single cardiologist blinded to Pediatric Sepsis Biomarker Risk Model II data, and sepsis-associated myocardial dysfunction was defined as left ventricular ejection fraction less than 45% for primary analyses. Multivariable logistic regression analyzed the association of Pediatric Sepsis Biomarker Risk Model II mortality probability with sepsis-associated myocardial dysfunction. Classification and regression tree methodology was employed to derive a Pediatric Sepsis Biomarker Risk Model biomarker-based model for sepsis-associated myocardial dysfunction. Thirty-two of 181 children with septic shock demonstrated sepsis-associated myocardial dysfunction. Pediatric Sepsis Biomarker Risk Model II mortality probability was independently associated with sepsis-associated myocardial dysfunction (odds ratio, 1.45; 95% CI, 1.17\u20131.81; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001). Modeling with Pediatric Sepsis Biomarker Risk Model biomarkers estimated sepsis-associated myocardial dysfunction risk with an area under the receiver operating characteristic curve of 0.90 (95% CI, 0.85\u20130.95). Upon 10-fold cross-validation, the derived model had a summary area under the receiver operating characteristic curve of 0.74. Model characteristics were similar when sepsis-associated myocardial dysfunction was defined by both low left ventricular ejection fraction and abnormal global longitudinal strain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>A newly derived Pediatric Sepsis Biomarker Risk Model biomarker-based model reliably estimates risk of sepsis-associated myocardial dysfunction in pediatric septic shock, but independent prospective validation is needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002830","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:15:02Z","timestamp":1632528902000},"page":"e20-e28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Pediatric Sepsis Biomarker Risk Model Biomarkers and Estimation of Myocardial Dysfunction in Pediatric Septic Shock"],"prefix":"10.1097","volume":"23","author":[{"given":"Andrew J.","family":"Lautz","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH."},{"name":"Division of Critical Care Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector R.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH."},{"name":"Division of Critical Care Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH."},{"name":"Division of Cardiology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Statile","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH."},{"name":"Division of Cardiology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0885066616685247","article-title":"Characterization of myocardial dysfunction in fluid- and catecholamine-refractory pediatric septic shock and its clinical significance.","volume":"34","author":"Williams","year":"2019","journal-title":"J Intensive Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"e0231","DOI":"10.1097\/CCE.0000000000000231","article-title":"Myocardial dysfunction is independently associated with mortality in pediatric septic shock.","volume":"2","author":"Lautz","year":"2020","journal-title":"Crit Care Explor"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jped.2017.02.005","article-title":"Role of echocardiography in reducing shock reversal time in pediatric septic shock: A randomized controlled trial.","volume":"94","author":"El-Nawawy","year":"2018","journal-title":"J Pediatr (Rio J)"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1542\/peds.102.2.e19","article-title":"Hemodynamic support in fluid-refractory pediatric septic shock.","volume":"102","author":"Ceneviva","year":"1998","journal-title":"Pediatrics"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/PCC.0b013e3182a5589c","article-title":"Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: A pilot observational study*.","volume":"15","author":"Ranjit","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00134-016-4675-y","article-title":"Fluid administration in severe sepsis and septic shock, patterns and outcomes: An analysis of a large national database.","volume":"43","author":"Marik","year":"2017","journal-title":"Intensive Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/CCM.0000000000002189","article-title":"Higher fluid balance increases the risk of death from sepsis: Results from a large international audit.","volume":"45","author":"Sakr","year":"2017","journal-title":"Crit Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/CCM.0000000000002425","article-title":"American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock.","volume":"45","author":"Davis","year":"2017","journal-title":"Crit Care Med"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PCC.0000000000000737","article-title":"Hemodynamic bedside ultrasound image quality and interpretation after implementation of a training curriculum for pediatric critical care medicine providers.","volume":"17","author":"Conlon","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PCC.0000000000002658","article-title":"Integrating focused cardiac ultrasound into pediatric septic shock assessment.","volume":"22","author":"Arnoldi","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1097\/PCC.0000000000002600","article-title":"Regulating critical care ultrasound, it is all in the interpretation.","volume":"22","author":"Su","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/PCC.0000000000002691","article-title":"A call to action for the pediatric critical care community.","volume":"22","author":"Conlon","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"eaax9000","DOI":"10.1126\/scitranslmed.aax9000","article-title":"Prospective clinical testing and experimental validation of the pediatric sepsis biomarker risk model.","volume":"11","author":"Wong","year":"2019","journal-title":"Sci Transl Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/rccm.201911-2187OC","article-title":"PERSEVERE biomarkers predict severe acute kidney injury and renal recovery in pediatric septic shock.","volume":"201","author":"Stanski","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/cc11652","article-title":"The pediatric sepsis biomarker risk model.","volume":"16","author":"Wong","year":"2012","journal-title":"Crit Care"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated pediatric risk of mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. The TRIPOD group.","volume":"131","author":"Collins","year":"2015","journal-title":"Circulation"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/CCM.0000000000004246","article-title":"Development and reporting of prediction models: Guidance for authors from editors of respiratory, sleep, and critical care journals.","volume":"48","author":"Leisman","year":"2020","journal-title":"Crit Care Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.echo.2016.03.018","article-title":"Pediatric reference values and Z score equations for left ventricular systolic strain measured by two-dimensional speckle-tracking echocardiography.","volume":"29","author":"Dallaire","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/bjoc.2001.1859","article-title":"Body surface area estimation in children using weight alone: Application in paediatric oncology.","volume":"85","author":"Sharkey","year":"2001","journal-title":"Br J Cancer"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0004-9514(14)60228-2","article-title":"The interpretation of diagnostic test: A primer for physiotherapists.","volume":"48","author":"Davidson","year":"2002","journal-title":"Aust J Physiother"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","article-title":"Refining clinical diagnosis with likelihood ratios.","volume":"365","author":"Grimes","year":"2005","journal-title":"Lancet"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00003246-198506000-00002","article-title":"Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock.","volume":"13","author":"Pollack","year":"1985","journal-title":"Crit Care Med"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MCC.0b013e3280c56afb","article-title":"What technique should I use to measure cardiac output?","volume":"13","author":"Hofer","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"R30-20250502","first-page":"CD003408","article-title":"Pulmonary artery catheters for adult patients in intensive care.","volume":"2013","author":"Rajaram","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.294.13.1664","article-title":"Impact of the pulmonary artery catheter in critically ill patients: Meta-analysis of randomized clinical trials.","volume":"294","author":"Shah","year":"2005","journal-title":"JAMA"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI112135","article-title":"A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.","volume":"76","author":"Parrillo","year":"1985","journal-title":"J Clin Invest"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.183.3.949","article-title":"Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.","volume":"183","author":"Kumar","year":"1996","journal-title":"J Exp Med"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/00003246-200210000-00003","article-title":"Characterization of a myocardial depressant factor in meningococcal septicemia.","volume":"30","author":"Pathan","year":"2002","journal-title":"Crit Care Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"H2500","DOI":"10.1152\/ajpheart.00432.2003","article-title":"Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor.","volume":"285","author":"Garner","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","article-title":"Mechanisms of sepsis-induced cardiac dysfunction.","volume":"35","author":"Rudiger","year":"2007","journal-title":"Crit Care Med"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00024382-199909000-00002","article-title":"Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds.","volume":"12","author":"Hoffmann","year":"1999","journal-title":"Shock"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"291","DOI":"10.33549\/physiolres.930946","article-title":"Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction.","volume":"56","author":"Joulin","year":"2007","journal-title":"Physiol Res"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1152\/jappl.1985.58.4.1199","article-title":"Hemodynamic effects of epinephrine: Concentration-effect study in humans.","volume":"58","author":"Stratton","year":"1985","journal-title":"J Appl Physiol (1985)"},{"key":"R40-20250502","first-page":"H692","article-title":"Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis.","volume":"268","author":"Karzai","year":"1995","journal-title":"Am J Physiol"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"H2498","DOI":"10.1152\/ajpheart.00793.2004","article-title":"Aging and cardiac responses to epinephrine in humans: Role of neuronal uptake.","volume":"288","author":"Leenen","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:34:08Z","timestamp":1746207248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002830","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}